gene_symbol
FCRL5
hgnc_id
HGNC:18508
binding_type
antigen recognition
cytotoxicity
YES
cytotoxicity_type
DIRECT
cytotoxicity_mechanism
Cevostamab bridges CD3 on T cells to FCRH5 on target cells, activating T cells to kill FCRH5-expressing cells via perforin/granzyme-mediated cytotoxicity.
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
Binds FCRH5 on malignant plasma cells; 2:1 bivalent binding arm
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT05583617
disease_id_num_tar_ref
2976
drug_id_num_tar_ref
7965